Figures
In Fig 4, the labels on the right side of A, “raMPV/B-PM-EGFP P5, 10, 15, 20”, have been changed to “raMPV/A-PM-EGFP P5, 10, 15, 20” and the label “raMPV-C-HA” in B has been changed to “raMPV/A-EGFP”. Please see the correct Fig 4 here.
Genetic stability analysis of raMPV/A-PM-EGFP (the optimal recombinant strain) after serial passage (P5, P10, P15, P20; passage 5, 10, 15, 20) in Vero cells, with parental aMPV/C as the negative control and chicken β-actin as the internal reference protein. A Indirect immunofluorescence assay (IFA) for the detection of aMPV-F protein expression in raMPV/A-PM-EGFP at different passages. Scale bar = 100 μm. B Western blotting (WB) analysis of aMPV-F protein and EGFP expression in serially passaged raMPV/A-PM-EGFP. Primary antibodies included a monoclonal antibody against aMPV-F, a specific antibody against EGFP, and a monoclonal antibody against chicken β-actin. Lanes are as follows: 1 = parental aMPV/C (negative control); 2 = raMPV/A-PM-EGFP P5; 3 = raMPV/A-PM-EGFP P10; 4 = raMPV/A-PM-EGFP P15; 5 = raMPV/A-PM-EGFP P20.
Reference
Citation: Guo Y, Xue T, Lu B, Zheng J, Wang Y, Xie X, et al. (2026) Correction: Identification of an optimal exogenous gene insertion site (P–M) and establishment of a reverse genetics system for aMPV/A. PLoS One 21(9): e0358322. https://doi.org/10.1371/journal.pone.0358322
Published: September 11, 2026
Copyright: © 2026 Guo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.